Telmisartan/Amlodipine Tablet 40/5 mg

Adult dose

The recommended dosage is one tablet once daily, to be taken with water regardless of meals. It is advised to take it at the same time each day (e.g., in the morning) if possible. If blood pressure is not adequately controlled, the dosage may be adjusted to 40/5 mg, 80/5 mg, or 40/10 mg. For patients with renal impairment, treatment should start at a lower dose in severe cases, while patients with liver impairment should not exceed a daily dosage of 40 mg.

Child dose

Safety and efficacy for pediatric patients under 18 years of age have not been established, so administration of this medication is not recommended.

This medication may cause serious side effects and risk of death to the fetus or neonate, particularly during the second and third trimesters of pregnancy; therefore, it should not be taken by women who are pregnant or may become pregnant. Individuals allergic to any ingredients in this medication, patients with severely impaired liver or heart function, and those with certain kidney diseases should not take it. Patients with specific conditions should be cautious when administering this medication, especially if they have liver dysfunction or gastrointestinal diseases. Common side effects such as dizziness or peripheral edema may occur, and rarely severe side effects can arise, so if any unusual symptoms occur, consult a physician immediately. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and an alternative treatment should be sought. Symptoms of hypotension may occur, so patients who are particularly dehydrated or salt-depleted should check their condition carefully before administration and adjust the dosage according to a physician’s instructions if necessary. This medication can increase potassium levels in the blood, so patients at risk of hyperkalemia need to undergo regular blood tests. Patients with impaired kidney function should have their kidney function and serum electrolyte levels monitored periodically while taking this medication. This medication may interact with other drugs, so inform a physician or pharmacist about any medications currently being taken. It is also safer for breastfeeding women not to take this medication. Safety and efficacy for children or adolescents under 18 years of age have not been sufficiently established, so it is not recommended for them. Elderly patients may respond more sensitively to this medication, so caution is necessary during administration and dosage adjustments may be required. In case of overdose, symptoms such as hypotension, dizziness, and heart problems may arise, so seek medical attention immediately for appropriate treatment. This medication should be stored out of the reach of children, taken immediately after opening, and not transferred to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of mouth/eyes, difficulty or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and extremely severe headaches, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urine

Mild side effects

• Dizziness
• peripheral edema
• fainting
• drowsiness
• headache
• sensory disturbances
• taste disturbances
• tremors
• visual impairment
• vertigo

This medication should be stored in a tightly closed container that blocks light and kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will keep the active ingredients stable and ensure safe use.

Appearance

White and light blue, bilaterally convex, oval double-coated tablet

Package unit

30 tablets (10 tablets/PTP*3)